Photo: Hemant Mishra/MintNew Delhi: Sun Pharmaceutical Industries Ltd and International Centre for Genetic Engineering and Biotechnology (ICGEB) on Wednesday signed an agreement to develop a novel dengue vaccine targeted against all four serotypes of dengue virus (DENV). According to the agreement, ICGEB will “disclose and make available to Sun Pharma all such existing ICGEB knowhow as well as effective completion of technology transfer by ICGEB to Sun Pharma within stipulated timeframe”. ICGEB has conducted pre-clinical studies over the past seven years and developed the existing knowhow and patents for this dengue vaccine candidate, a statement from Sun Pharma added. A joint development committee, comprising members of both the organisations will be established to provide oversight to the dengue vaccine development programme. “Our pre-clinical data is very encouraging and this could be an ideal dengue vaccine candidate for all target populations,” said Dr Salunke, Director, ICGEB.

Source: Mint October 19, 2016 21:11 UTC